Latest news

Daily Snap - 17. November 2025

Daily Snap - 17. November 2025

Joachim Eeckhout
Lundbeck’s surprise bid throws Alkermes’ $2.1B deal for Avadel into doubt

Lundbeck’s surprise bid throws Alkermes’ $2.1B deal for Avadel into doubt

Eduardo Longoria
Merck catches a long-acting flu drug for $9.2B to replace vaccines

Merck catches a long-acting flu drug for $9.2B to replace vaccines

Eduardo Longoria
Daily Snap - 14. November 2025

Daily Snap - 14. November 2025

Joachim Eeckhout
Novartis discovers a new path to fight malaria’s drug resistance

Novartis discovers a new path to fight malaria’s drug resistance

Eduardo Longoria
FDA unveils a new roadmap for ultra-rare, custom-made therapies

FDA unveils a new roadmap for ultra-rare, custom-made therapies

Eduardo Longoria
Daily Snap - 13. November 2025

Daily Snap - 13. November 2025

Joachim Eeckhout
Pfizer launches bold challenge to Keytruda with PD-1xVEGF bispecific push

Pfizer launches bold challenge to Keytruda with PD-1xVEGF bispecific push

Eduardo Longoria
Alkermes hits narcolepsy trial goals but investors remain unimpressed

Alkermes hits narcolepsy trial goals but investors remain unimpressed

Eduardo Longoria
Daily Snap - 12. November 2025

Daily Snap - 12. November 2025

Joachim Eeckhout
Neurocrine’s depression drug fails trial, but investors shrug

Neurocrine’s depression drug fails trial, but investors shrug

Eduardo Longoria
Merck’s cholesterol pill could challenge injectables

Merck’s cholesterol pill could challenge injectables

Eduardo Longoria
FirstBack
12345678
Next Last